CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
67 hedge funds and large institutions have $1.11B invested in China Biologic Products Holdings, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $1.38B → $1.11B (-$269M)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
Holders
67
Holding in Top 10
8
Calls
$9.38M
Puts
$8.58M
Top Buyers
| 1 | +$22M | |
| 2 | +$14.8M | |
| 3 | +$5.38M | |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
+$3.05M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.07M |
Top Sellers
| 1 | -$220M | |
| 2 | -$72.9M | |
| 3 | -$70.6M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$34.1M |
| 5 |
Bank of New York Mellon
New York
|
-$15.1M |